 | • レポートコード：C-GIR20G2536 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「B細胞リンパ腫2阻害剤の世界市場2019年」は、グローバルにおけるB細胞リンパ腫2阻害剤市場を展望するレポートです。B細胞リンパ腫2阻害剤のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・B細胞リンパ腫2阻害剤の市場概観 ・B細胞リンパ腫2阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・B細胞リンパ腫2阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・B細胞リンパ腫2阻害剤の世界市場規模 ・B細胞リンパ腫2阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・B細胞リンパ腫2阻害剤のアメリカ市場規模推移 ・B細胞リンパ腫2阻害剤のカナダ市場規模推移 ・B細胞リンパ腫2阻害剤のメキシコ市場規模推移 ・B細胞リンパ腫2阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・B細胞リンパ腫2阻害剤のドイツ市場規模推移 ・B細胞リンパ腫2阻害剤のイギリス市場規模推移 ・B細胞リンパ腫2阻害剤のロシア市場規模推移 ・B細胞リンパ腫2阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・B細胞リンパ腫2阻害剤の日本市場規模推移 ・B細胞リンパ腫2阻害剤の中国市場規模推移 ・B細胞リンパ腫2阻害剤の韓国市場規模推移 ・B細胞リンパ腫2阻害剤のインド市場規模推移 ・B細胞リンパ腫2阻害剤の東南アジア市場規模推移 ・B細胞リンパ腫2阻害剤の南米市場分析（ブラジル、アルゼンチン等） ・B細胞リンパ腫2阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・B細胞リンパ腫2阻害剤の種類別分析/販売量、売上、市場シェア（併用療法、単剤療法） ・B細胞リンパ腫2阻害剤の用途別分析/市場規模（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病 ） ・B細胞リンパ腫2阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・B細胞リンパ腫2阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global B-cell lymphoma 2 Inhibitors market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of B-cell lymphoma 2 Inhibitors.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the B-cell lymphoma 2 Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the B-cell lymphoma 2 Inhibitors market by product type and applications/end industries.
Market Segment by Companies, this report covers
AbbVie Inc.
Tocris
F. Hoffmann-La Roche Ltd.
Santa Cruz Biotechnology
Biovision
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Combination Therapy
Monotherapy
Market Segment by Applications, can be divided into
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Cute Myeloid Leukemia
Table of Contents
1 B-cell lymphoma 2 Inhibitors Market Overview
1.1 Product Overview and Scope of B-cell lymphoma 2 Inhibitors
1.2 Classification of B-cell lymphoma 2 Inhibitors by Types
1.2.1 Global B-cell lymphoma 2 Inhibitors Revenue Comparison by Types (2019-2024)
1.2.2 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Types in 2018
1.2.3 Combination Therapy
1.2.4 Monotherapy
1.3 Global B-cell lymphoma 2 Inhibitors Market by Application
1.3.1 Global B-cell lymphoma 2 Inhibitors Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Small Lymphocytic Lymphoma
1.3.4 Cute Myeloid Leukemia
1.4 Global B-cell lymphoma 2 Inhibitors Market by Regions
1.4.1 Global B-cell lymphoma 2 Inhibitors Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) B-cell lymphoma 2 Inhibitors Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) B-cell lymphoma 2 Inhibitors Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) B-cell lymphoma 2 Inhibitors Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) B-cell lymphoma 2 Inhibitors Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) B-cell lymphoma 2 Inhibitors Status and Prospect (2014-2024)
1.5 Global Market Size of B-cell lymphoma 2 Inhibitors (2014-2024)
2 Company Profiles
2.1 AbbVie Inc.
2.1.1 Business Overview
2.1.2 B-cell lymphoma 2 Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Inc. B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.2 Tocris
2.2.1 Business Overview
2.2.2 B-cell lymphoma 2 Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Tocris B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 Business Overview
2.3.2 B-cell lymphoma 2 Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.4 Santa Cruz Biotechnology
2.4.1 Business Overview
2.4.2 B-cell lymphoma 2 Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.5 Biovision
2.5.1 Business Overview
2.5.2 B-cell lymphoma 2 Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biovision B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
3 Global B-cell lymphoma 2 Inhibitors Market Competition, by Players
3.1 Global B-cell lymphoma 2 Inhibitors Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 B-cell lymphoma 2 Inhibitors Players Market Share
3.2.2 Top 10 B-cell lymphoma 2 Inhibitors Players Market Share
3.3 Market Competition Trend
4 Global B-cell lymphoma 2 Inhibitors Market Size by Regions
4.1 Global B-cell lymphoma 2 Inhibitors Revenue and Market Share by Regions
4.2 North America B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
4.3 Europe B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
4.5 South America B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
5 North America B-cell lymphoma 2 Inhibitors Revenue by Countries
5.1 North America B-cell lymphoma 2 Inhibitors Revenue by Countries (2014-2019)
5.2 USA B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
5.3 Canada B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
5.4 Mexico B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
6 Europe B-cell lymphoma 2 Inhibitors Revenue by Countries
6.1 Europe B-cell lymphoma 2 Inhibitors Revenue by Countries (2014-2019)
6.2 Germany B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
6.3 UK B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
6.4 France B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
6.5 Russia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
6.6 Italy B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
7 Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue by Countries
7.1 Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue by Countries (2014-2019)
7.2 China B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
7.3 Japan B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
7.4 Korea B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
7.5 India B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
8 South America B-cell lymphoma 2 Inhibitors Revenue by Countries
8.1 South America B-cell lymphoma 2 Inhibitors Revenue by Countries (2014-2019)
8.2 Brazil B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
8.3 Argentina B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
8.4 Colombia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue B-cell lymphoma 2 Inhibitors by Countries
9.1 Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue by Countries (2014-2019)
9.2 Saudi Arabia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
9.3 UAE B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
9.4 Egypt B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
9.5 Nigeria B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
9.6 South Africa B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
10 Global B-cell lymphoma 2 Inhibitors Market Segment by Type
10.1 Global B-cell lymphoma 2 Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 Global B-cell lymphoma 2 Inhibitors Market Forecast by Type (2019-2024)
10.3 Combination Therapy Revenue Growth Rate (2014-2024)
10.4 Monotherapy Revenue Growth Rate (2014-2024)
11 Global B-cell lymphoma 2 Inhibitors Market Segment by Application
11.1 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Application (2014-2019)
11.2 B-cell lymphoma 2 Inhibitors Market Forecast by Application (2019-2024)
11.3 Chronic Lymphocytic Leukemia Revenue Growth (2014-2019)
11.4 Small Lymphocytic Lymphoma Revenue Growth (2014-2019)
11.5 Cute Myeloid Leukemia Revenue Growth (2014-2019)
12 Global B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2024)
12.1 Global B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2024)
12.2 Global B-cell lymphoma 2 Inhibitors Market Forecast by Regions (2019-2024)
12.3 North America B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
12.4 Europe B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
12.6 South America B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure B-cell lymphoma 2 Inhibitors Picture
Table Product Specifications of B-cell lymphoma 2 Inhibitors
Table Global B-cell lymphoma 2 Inhibitors and Revenue (Million USD) Market Split by Product Type
Figure Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Types in 2018
Figure Combination Therapy Picture
Figure Monotherapy Picture
Table Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) by Application (2014-2024)
Figure B-cell lymphoma 2 Inhibitors Revenue Market Share by Applications in 2018
Figure Chronic Lymphocytic Leukemia Picture
Figure Small Lymphocytic Lymphoma Picture
Figure Cute Myeloid Leukemia Picture
Table Global Market B-cell lymphoma 2 Inhibitors Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Table AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table AbbVie Inc. B-cell lymphoma 2 Inhibitors Type and Applications
Table AbbVie Inc. B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Tocris Basic Information, Manufacturing Base and Competitors
Table Tocris B-cell lymphoma 2 Inhibitors Type and Applications
Table Tocris B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Type and Applications
Table F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Type and Applications
Table Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Biovision Basic Information, Manufacturing Base and Competitors
Table Biovision B-cell lymphoma 2 Inhibitors Type and Applications
Table Biovision B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) by Players (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Revenue Share by Players (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Share by Players in 2017
Figure Global B-cell lymphoma 2 Inhibitors Revenue Share by Players in 2018
Figure Global Top 5 Players B-cell lymphoma 2 Inhibitors Revenue Market Share in 2018
Figure Global Top 10 Players B-cell lymphoma 2 Inhibitors Revenue Market Share in 2018
Figure Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) by Regions (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Regions in 2018
Figure North America B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Europe B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure South America B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Table North America B-cell lymphoma 2 Inhibitors Revenue by Countries (2014-2019)
Table North America B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries in 2018
Figure USA B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Canada B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Mexico B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Europe B-cell lymphoma 2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Europe B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries in 2018
Figure Germany B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure UK B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure France B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Russia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Italy B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries in 2018
Figure China B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Japan B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Korea B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure India B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Southeast Asia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Table South America B-cell lymphoma 2 Inhibitors Revenue by Countries (2014-2019)
Table South America B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Argentina B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Colombia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue Market Share by Countries in 2018
Figure Saudi Arabia B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure UAE B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Egypt B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Nigeria B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure South Africa B-cell lymphoma 2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) by Type (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Revenue Share by Type (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Share by Type (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Share by Type in 2018
Table Global B-cell lymphoma 2 Inhibitors Revenue Forecast by Type (2019-2024)
Figure Global B-cell lymphoma 2 Inhibitors Market Share Forecast by Type (2019-2024)
Figure Global Combination Therapy Revenue Growth Rate (2014-2019)
Figure Global Monotherapy Revenue Growth Rate (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Revenue by Application (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Revenue Share by Application (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Share by Application (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Share by Application in 2018
Table Global B-cell lymphoma 2 Inhibitors Revenue Forecast by Application (2019-2024)
Figure Global B-cell lymphoma 2 Inhibitors Market Share Forecast by Application (2019-2024)
Figure Global Chronic Lymphocytic Leukemia Revenue Growth Rate (2014-2019)
Figure Global Small Lymphocytic Lymphoma Revenue Growth Rate (2014-2019)
Figure Global Cute Myeloid Leukemia Revenue Growth Rate (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global B-cell lymphoma 2 Inhibitors Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Market Share Forecast by Regions (2019-2024)
Figure North America B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Europe B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Asia-Pacific B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
Figure South America B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Middle East and Africa B-cell lymphoma 2 Inhibitors Revenue Market Forecast (2019-2024)
未分化リンパ腫キナーゼ阻害剤の世界市場 2019年版：種類別（クリゾチニブ、セリチニブ、塩酸アレクチニブ）、用途別（NSCLC、乳がん、大腸がん、神経芽細胞腫、卵巣がん、その他） Scope of the Report: The worldwide market for Anaplastic Lymphoma Kinase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the A…- 世界のホジキンリンパ腫薬市場予測（～2024年） Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. Those affecte…
- 悪性リンパ腫市場：世界及び中国市場分析・予測（～2024年） Malignant Lymphoma Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Malignant Lymphoma industry with a focus on the Chinese market. The report provides key statistics on the market status of the Malignant Lymphoma manufacturers…
- バーキットリンパ腫用治療市場：世界及び中国市場分析・予測（～2024年） Burkitt Lymphoma Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Burkitt Lymphoma Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Burkitt Lymphoma…
- 無痛性リンパ腫治療市場：世界及び中国市場分析・予測（～2024年） Indolent Lymphoma Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Indolent Lymphoma Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Indolent Lymph…